1127:. In contrast to courts, which have a wide range of remedies at their disposal, including monetary damages, the ITC can grant only two forms of remedy: exclusion orders barring infringing products from being imported into the United States, and cease-and-desist orders preventing the defendants (known as respondents) in the ITC action from importing infringing products into the United States. In addition, the ITC can grant temporary relief, similar to a preliminary injunction in U.S. federal court, which prevents importation of allegedly infringing products for the duration of the ITC proceeding. In some cases, this may provide a quicker resolution to a patent owner's problems.
990:
2821:
1009:(USPTO). Prior to June 7, 1995, the duration of a US utility patent was 17 years from patent issuance. Since that date, the duration of the US utility patent is 20 years from the earliest effective filing date. However, patent term adjustment or extension are possible if the USPTO fails to issue a patent within 3 years after filling the full application, subject to various conditions on the applicant. The rules for drafting and filing a patent application are set out in the
998:
33:
1044:
757:. The "patentability" of inventions (defining the types things that qualify for patent protection) is defined under Sections 100–105. Most notably, section 101 sets out "subject matter" that can be patented; section 102 defines "novelty" and "statutory bars" to patent protection; section 103 requires that an invention to be "non-obvious".
625:. A patent is the right to exclude others, for a limited time (usually, 20 years) from profiting from a patented technology without the consent of the patent holder. Specifically, it is the right to exclude others from: making, using, selling, offering for sale, importing, inducing others to infringe, applying for an
813:
There are four types of "anything" (i.e. of statutory categories of inventions): a process, a machine (usually implies moving parts), (an article of) manufacture (usually implies no moving parts, e.g. textile fabric or a chair), a composition of matter (chemicals, materials), as well as improvements
968:
The non-obviousness requirement does not demand that the prior art be identical to the claimed invention. It is enough that the prior art can somehow be modified (or combined) in order to teach the claimed technology. So long as the modification of the prior art (or combination of several prior art
1175:
have been introduced or developed without having patent protection. All others—petroleum, machinery, fabricated metal products, primary metals, electrical equipment, instruments, office equipment, motor vehicles, rubber, and textiles—have a percentage of twenty-five or lower, with the last four of
1170:
However, this is not to say that all industries believe their inventions have relied on the patent system or believe it is a necessity to introduce and develop inventions. Another survey for the same time period show that, of those 12 same industries, only two—pharmaceuticals and chemicals—believe
931:
The issue of novelty is often arises during patent examination, because of inadvertent and/or partial disclosures by inventors themselves prior to filing a patent application. Unlike the laws of most countries, the US patent law provides for a one-year grace period in cases of inventor's own prior
1338:
1789. U.S. Constitution in
Article I, Section 8, Clause 8 authorizes Congress “to promote the Progress of . . . useful Arts, by securing for limited Times to . . . Inventors the exclusive Right to their . . . Discoveries." it is believed, that unlike most parts of the US Constitution, which were
963:
35 U.S.C. 103 Conditions for patentability; non-obvious subject matter. A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are
1029:
applications 18 months after the earliest priority application (which often is a provisional application) is filed. This time limit can be extended under certain circumstances, for an additional fee. The applications may be published before a patent has been granted on them if the patent is not
954:
requirement in other countries. An "invention" is obvious (and therefore ineligible for a patent), if a person of "ordinary skill" in the relevant field of technology would have thought the technology was obvious, on the filing date of the patent application. Legislatively the requirement for
749:
fall under exclusive jurisdiction of the
Federal government. On the other hand, questions of patent ownership (like other questions of private property) are contested in state courts, although federal courts can make decisions about patent ownership by applying the relevant state law, when
915:(a) NOVELTY; PRIOR ART.—A person shall be entitled to a patent unless— (1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention ...
2760:
969:
references) would have been obvious to a person having ordinary skill in the art (PHOSITA) at the time the application was filed, the applied-for technology will be considered obvious and therefore patent-ineligible under 35 U.S.C. §103.
2806:
Fiddling with
Federal Circuit Precedent: The Commercial and Qualitative Impact of Recent Supreme Court Reversals on the U.S. Patent System. 2020. Fordham Intellectual Property, Media & Entertainment Law Journal. 30/3, 935. C.J.
923:
of the claimed invention either explicitly or impliedly. "A claim is anticipated only if each and every element as set forth in the claim is found, either expressly or inherently described, in a single prior art reference."
2817:
2757:
964:
such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains.
651:
The
Congress shall have power ... To promote the progress of science and useful arts, by securing for limited times to authors and inventors the exclusive right to their respective writings and discoveries;
2019:
972:
As the practice of the USPTO and US Federal Courts showed later, the PHOSITA criterion turned out to be too ambiguous in practice. The practical approach was developed later by the US Supreme Court in
1346:
1790. First Patent Act empowered the
Secretary of State, the Secretary for the Department of War, and the Attorney General to examine patents for inventions deemed “sufficiently useful and important.”
888:) is not patent-ineligible in the US, since the new elements in such inventions are not "made" but rather "discovered" by man. Although the presence of such "discoveries" helps patentees to meet the
1357:
description shall "distinguish the same from all other things before known," and in "the case of any machine" shall, explain the "principle... by which it may be distinguished from other inventions."
911:
Section 102 of the patent act defines the "novelty" requirement. The novelty requirement prohibits patenting a technology that is already available to the public. Specifically, 35 U.S.C. 102 states:
2328:
1628:
1624:
881:
865:
1431:
in the nearly exact language used today: “particularly point out and distinctly claim the part, improvement, or combination which he claims as his invention or discovery.” The practice of
1167:
A survey of 12 industries from 1981 to 1983 shows that patent utilization is strong across all industries in the United States, with 50 percent or more patentable inventions being patented.
2657:
1893:. This statute allows the US government to override patent protection (or contract another entity to do so) for public-use purposes. The patent owner can sue for limited compensation.
1971:
1522:
1148:
857:
427:
1658:
2818:
http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ResearchSoft&SrcApp=EndNote&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000258787100001
2495:
2164:
1123:(ITC) instead of, or in addition to, the court system. The ITC is an agency of the U.S. federal government empowered to enforce patent holders' rights under Section 337 of the
659:
2758:
https://heinonline.org/HOL/Page?public=true&handle=hein.journals/jpatos20&div=20&start_page=134&collection=journals&set_as_cursor=0&men_tab=srchresults
2000:
814:
thereof. Not every object falls into a statutory category: for example, electromagnetic waves, rules for playing games are not patentable (but a new and non-obvious type of
655:
Although this statement is superficially similar to intellectual property clauses in the constitutions of other countries, the US patent system has several peculiarities.
936:, which allows an inventor to establish a priority and gives them a year to improve on their invention before filing a complete (i.e. non-provisional) patent application.
592:
1064:
In the first sentence, the wording "... can be found here:" followed by a footnote is really not optimal. If the URL becomes dead, the sentence basically cannot be saved.
822:
be patentable as a "manufacture"). The most significant restrictions occurred over time with respect to patentability of "processes" (methods). For example, patenting of
1977:
2435:
1631:
the SCOTUS limited patentability of inventions based on newly-discovered natural phenomena, requiring a further "inventive concept" instead of routine applications.
561:
2547:
2091:
1496:
to review validity of issued patents at the request of patent owners and third parties. However, the process was slow and usually favored patent owners in result.
1949:
1845:
797:
1353:
requirement. This Act did not have a requirement for claims, but it mandated a distinction "from...other things...and from other inventions" in the description:
2926:
1500:
640:
810:
and US courts interpreted both "anything" and "made by man" quite broadly. However, the meaning of these terms has been narrowed substantially over the years.
2787:
WIPO International Patent Case
Management Judicial Guide: United States. 2022. SSRN Electronic Journal. P.S. Menell, A.A. Schmitt. doi: 10.2139/ssrn.4106648.
2354:
2046:
1120:
945:
525:
2521:
2324:
2254:
Testimony of P. J. Federico in hearings on H.R. 3760 before
Subcommittee No. 3 of the House Committee on the Judiciary, 82d Cong., 1st Sess., 37 (1951).
2225:
2207:
2177:
2302:
1983:
1955:
1068:
1006:
841:
510:
2747:
The
Overlooked French Influence on the Intellectual Property Clause. 2015. Univ Chic Law Rev. 82/2, 733-830. S. O'Connor. doi: 10.2139/ssrn.2409796.
1136:
781:
1111:. 5000-6000 patent cases are filed each year in the United States. The two most popular districts for patent cases are E.D. Texas and D. Delaware.
723:
is allowed for using patented product or process for research and educational purposes, albeit their scopes have seen reductions in recent years.
665:
Secondly, until 16 March 2013 the US gave priority to first inventors to invent, although the US adopted first inventor to file system since (see
556:
201:
2845:
2414:
676:, which can be filed one year before filing regular patent application, thus delaying the start on the nominal 20 year patent term by one year.
2816:
Concept of obviousness: Scenario post KSR International v
Teleflex Inc. 2008. J Intel Prop Rights. 13/1, 7-18. A. Pareek, S. Singh. HYPERLINK "
2578:
585:
566:
2380:
2272:
1890:
1720:
1647:
893:
834:
658:
Firstly, this clause is interpreted as giving the primary IP rights only to individuals (i.e. "inventors") rather than to organizations (see
2646:
2465:
1678:
1010:
900:
545:
382:
1030:
granted within the 18-month time frame. Applicants can opt out of publication if the applications will not be prosecuted internationally.
432:
2791:
1860:
950:
To be patentable, a technology must not only be "new" but also "non-obvious." The US requirement for non-obviousness corresponds to the
680:
551:
540:
196:
772:
have primary jurisdiction in patent infringement cases. Patent validity can be challenged in the same US Federal
District courts, as a
2487:
1966:
1795:
1740:
754:
622:
520:
437:
186:
3193:
3172:
3142:
3047:
2919:
1086:
1022:
776:
or counter-claim of non-infringement. Alternatively, patent validity (or examiners' refusals to grant patents) can be challenged at
666:
578:
412:
2682:
2609:
1552:
introduced earlier, this process failed to gain popularity, in part due to being slow and to barring subsequent civil litigation.
1760:
3167:
1119:
In cases involving importation of a patented product into the US, the patent holder may wish to pursue a cause of action in the
3057:
1989:
919:
For a technology to be "anticipated" (and therefore patent-ineligible) under 35 U.S.C. 102, the prior art reference must teach
868:(2013), that "mere isolation of genes does not qualify for patent protection". At the same time the Court allowed patenting of
852:
implementations of a newly discovered natural phenomenon or natural product are not eligible for a patent. However, in 1991 in
673:
3097:
3147:
1735:
1583:
1144:
933:
860:
concluded that genes isolated from their natural environment were patentable. This practice came to an end in 2013 when the
784:(CAFC) reviews the decisions of the Federal District Courts and of the PTAB. The rulings of the CAFC can be reviewed by the
613:
is a right granted to the inventor of a (1) process, machine, article of manufacture, or composition of matter, (2) that is
605:
The United States is considered to have the most favorable legal regime for inventors and patent owners in the world. Under
2431:
679:
Fourthly, unlike most other countries, the US allows extension of patent monopoly beyond 20 years from the filing date via
2987:
1705:
777:
515:
279:
54:
3037:
2410:
Amgen, Inc. v. Chugai Pharmaceutical Co., Ltd., 927 F. 2d 1200—Court of Appeals, Federal Circuit 1991. Available online:
3157:
2912:
1820:
833:
and 2014, but courts gradually curtailed patentability of business methods to the point of almost complete exclusion in
684:
356:
3052:
2947:
1124:
1059:
806:
stated that patentable subject matter should encompass "anything under the sun that is made by man." At that time, the
45:
3152:
3102:
1995:
1810:
3137:
2350:
853:
3162:
1541:
1463:
1140:
769:
636:
2042:
1961:
1928:
1923:
1386:
1378:
1350:
243:
222:
171:
2756:
Evolution of the Claims of U. S. Patents. 1938. Journal of the Patent Office Society. 20/2, 134-56,. K.B. Lutz.
3132:
3042:
2992:
2952:
2517:
1936:
1805:
1594:
1176:
those industries believing none of their inventions relied on the patent system to be introduced or developed.
974:
606:
375:
191:
3127:
3122:
3117:
3107:
2972:
3112:
3027:
3002:
2233:
2211:
2185:
1508:
880:
applications of discoveries (such as that different people metabolize the same drug at different rates as in
3077:
3012:
2982:
2957:
2890:
1825:
1771:
1394:
3087:
3017:
2997:
2294:
1548:
to review validity of issued patents with participation of third party challengers. However, just like the
989:
3032:
3022:
2962:
1815:
1549:
1530:
1489:
1374:
453:
305:
3007:
1390:
3092:
2977:
2118:"Research Use Exemptions to Patent Infringement for Drug Discovery and Development in the United States"
1913:
1896:
1830:
1715:
1439:
1332:
773:
709:
458:
422:
249:
140:
109:
104:
1405:
1398:
1432:
726:
Ninthly, the large size of the US economy, the strong pro-patentee legal regime and over 200 years of
2967:
2837:
2411:
1556:
114:
2570:
2401:
1. Go (EN) FISH: DRAWING CAD FILES FROM THE PATENT ELIGIBILITY POOL 2017. IDEA. 58/1. A. Schreiber.
1643:
1054:
3082:
2376:
2264:
1855:
1840:
1835:
1790:
1776:
1766:
1755:
1609:
1571:. Instead the same traditional four-factor test of equity used outside of patent law is mandated.
1568:
1417:
1108:
746:
712:
are prohibited in the USA in general, they are allowed in cases of potential patent infringement.
484:
368:
351:
274:
264:
259:
254:
155:
2872:
48:, as (for example) the introduction does not appear to properly summarize the body of the article.
1918:
1908:
1902:
1750:
1730:
1447:
1156:
956:
885:
803:
716:
698:
227:
135:
130:
2457:
417:
2631:
1340:
840:
Also, US courts have been struggling with the meaning of "made by man". Since at least 1948 in
2895:
2788:
2147:
1700:
1695:
1602:
869:
788:, but only on a discretionary basis (i.e. there is no right to appeal the CAFC's decisions).
300:
269:
176:
2730:
2543:
2518:"Inventor grace period: When is it too late to file a US patent after disclosing invention?"
2137:
2129:
1865:
1850:
1639:
1635:
1421:
1382:
1152:
823:
644:
618:
614:
463:
315:
181:
145:
2825:
2795:
2764:
2418:
1781:
1745:
1613:
1598:
1587:
1575:
1560:
1478:
1459:
1455:
1413:
1370:
889:
702:
489:
468:
341:
320:
310:
1586:". Nevertheless, many legal commentators praised the ruling as the need for raising the
997:
32:
2693:
2601:
2142:
2117:
1725:
1579:
978:
951:
691:
683:
due to the patent prosecution delays by the USPTO or due to product approval delays by
1099:
A table, summarizing post-grant proceedings available in the USA, can be found here:
3187:
1710:
1662:
1654:
1617:
1428:
1409:
1362:
734:
730:
make US patents more valuable and more litigated, than patents of any other country.
535:
530:
494:
1582:, thus overruling "a clear, bright-line test in § 103 obviousness inquiries such as
2069:
1526:
1519:
629:
approval, and/or offering a product specially adapted for practice of the patent.
346:
99:
1349:
1793. Second Patent Act eliminated examination of patent applications, emphasized
899:
Patent subject matter eligibility is discussed in the details in section 2106 of
892:
requirement, an additional man-made contribution (called "inventive concepts" in
2878:
2133:
1800:
1564:
1537:
1515:
1485:
2904:
2721:
Mansfield, Edwin (February 1986). "Patent and Innovation: An Emprical Study".
1666:
765:
325:
1529:
pharmaceutical manufacturers to challenge the validity of wrongfully issued
1470:
206:
2151:
1335:, which has been acknowledged as a legal predecessor of the US patent law.
17:
2734:
1870:
1474:
1451:
1366:
1361:
1836. Third Patent Act re-introduced examination, recommended the use of
761:
727:
720:
635:
is codified in Title 35 of the United States Code, and authorized by the
873:
150:
1107:
Litigation in the Federal District Courts remains the main remedy for
876:, since "it does not exist" in nature. Similarly, inventions based on
1443:
1026:
884:, or that pregnant woman's blood contains DNA of fetus' father as in
861:
845:
785:
610:
94:
1469:
1952. Fifth Patent Act codified US patent law into Title 35 of the
2412:
https://casetext.com/case/amgen-inc-v-chugai-pharmaceutical-co-ltd
1545:
1504:
1493:
1424:, decided by a jury. This remains a binding precedent currently.
996:
988:
932:
disclosure. Another unique feature of the US patent practice is a
807:
1442:
introduced some remedies to limit abuses of patent monopoly. The
896:) is required to limit this discovery to a patentable invention.
826:
in US (in contrast to other countries) was quite common between
815:
2908:
2896:
Sarah Burstein, Sarah R. Wasserman Rajec & Andres Sawicki,
1503:, with exclusive jurisdiction over all patent appeals from the
1037:
626:
26:
2869:
United States Patent and Trademark Office (USPTO) web site:
1689:
1171:
thirty percent or more of their patentable inventions would
882:
Mayo Collaborative Services v. Prometheus Laboratories, Inc.
866:
Association for Molecular Pathology v. Myriad Genetics, Inc.
2789:
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4106648
2020:"International Intellectual Property Index by country 2023"
2883:
1650:
albeit stopped short of banning such patents completely.
2351:"History of Software Patents and Business Method Patents"
2092:"Preempting Patent Enforcement Prior to Product Launches"
2070:"Using Declaratory Judgments Offensively in Patent Cases"
1408:
the US Supreme Court decided, that the interpretation of
1669:, who initiate and lose in "frivolous" patent lawsuits.
2458:"Patent Subject Matter Eligibility [R-10.2019]"
1155:, but only on discretionary basis via a petition for a
50:
1972:
United States Court of Appeals for the Federal Circuit
1659:
Octane Fitness, LLC v. ICON Health & Fitness, Inc.
1523:
Drug Price Competition and Patent Term Restoration Act
1578:
determination by mixing it up with predictability in
733:
The ninth advantage gave rise to the system abuse by
2632:"Chart Summarizing Different Post Grant Proceedings"
2432:"U.S. Supreme Court Strikes Down Human Gene Patents"
2165:
Stanford University v. Roche Molecular Systems, Inc.
1653:
2014. In a move widely regarded as directed against
1634:
2014. The US Supreme Court limited patentability of
660:
Stanford University v. Roche Molecular Systems, Inc.
3066:
2940:
2716:
2714:
2001:
List of United States Supreme Court patent case law
2488:"Training materials on subject matter eligibility"
1978:United States Court of Customs and Patent Appeals
2295:"In re Nuijten | Case Brief for Law School"
768:that have accumulated over more than 200 years.
1131:Court of Appeals for the Federal Circuit (CAFC)
1034:Patent infringement, enforcement and litigation
961:
913:
737:, which are largely absent in other countries.
649:
164:Patentability requirements and related concepts
2043:"Patent Term Adjustment | Sterne Kessler"
1950:American Intellectual Property Law Association
1339:derived from the British legal tradition, the
926:Verdegaal Bros. v. Union Oil Co. of California
798:Patentable subject matter in the United States
2920:
1501:U.S. Court of Appeals for the Federal Circuit
586:
376:
8:
1574:2007. The SCOTUS created uncertainty in the
1427:1870. Fourth Patent Act required the use of
1121:United States International Trade Commission
2122:Cold Spring Harbor Perspectives in Medicine
1416:, decided by a judge, while the finding of
1188:Percent That Would Not Have Been Developed
1185:Percent That Would Not Have Been Introduced
946:Non-obviousness in United States patent law
2927:
2913:
2905:
2325:"Are Rules for Playing a Game Patentable?"
593:
579:
394:
383:
369:
78:
2141:
1984:United States Patent and Trademark Office
1956:Board of Patent Appeals and Interferences
1115:U.S. International Trade Commission (ITC)
1087:Learn how and when to remove this message
1007:United States Patent and Trademark Office
903:. Additional examples can be found here.
842:Funk Bros. Seed Co. v. Kalo Inoculant Co.
753:Most of the US patent law is codified in
511:United States Patent and Trademark Office
1466:to limit proliferation of weak patents.
1178:
1137:Court of Appeals for the Federal Circuit
1005:Patent applications can be filed at the
782:Court of Appeals for the Federal Circuit
701:for patent infringement in the US, only
2783:
2781:
2011:
1369:developed rudimentary requirements for
955:non-obviousness was established in the
502:
476:
445:
404:
397:
333:
292:
235:
214:
163:
122:
86:
81:
2612:from the original on February 10, 2013
2265:"Manual of Patent Examining Procedure"
928:, 814 F.2d 628, 631 (Fed. Cir. 1987).
2663:from the original on January 25, 2023
2544:"Term of patent in the United States"
1721:Doctrine of repair and reconstruction
1648:Alice Corp. v. CLS Bank International
959:.Specifically, 35 U.S.C. 103 states:
894:Alice Corp. v. CLS Bank International
835:Alice Corp. v. CLS Bank International
760:The US also has an extensive body of
7:
2848:from the original on January 3, 2007
2550:from the original on August 18, 2020
1679:Timeline of United States inventions
1011:Manual of Patent Examining Procedure
901:Manual of Patent Examining Procedure
546:Manual of Patent Examining Procedure
2898:Patent Law: An Open-Access Casebook
2838:"Infringement for the public good?"
1861:United States Defensive Publication
1103:U.S. Federal District Courts (FDCs)
2581:from the original on June 21, 2008
2498:from the original on June 10, 2023
2468:from the original on June 10, 2023
2275:from the original on June 13, 2023
2116:Russo, A. A.; Johnson, J. (2015).
1967:Copyright law of the United States
1905:, First Patent Act - April 7, 1790
1796:Non-provisional patent application
1563:’s practice of liberally granting
1343:was based on the French practice.
755:Title 35 of the United States Code
745:The issues of patent validity and
438:Title 35 of the United States Code
187:Inventive step and non-obviousness
25:
2524:from the original on June 5, 2023
2438:from the original on May 30, 2023
2383:from the original on May 17, 2023
2357:from the original on June 1, 2023
2331:from the original on May 31, 2023
2305:from the original on May 31, 2023
2049:from the original on May 31, 2023
1023:American Inventors Protection Act
708:Seventhly, although lawsuits for
667:First to file and first to invent
413:American Inventors Protection Act
44:to comply with Knowledge (XXG)'s
3048:Saint Vincent and the Grenadines
2647:"IP Litigation in United States"
2074:J. Marshall Rev. Intell. Prop. L
1846:Statutory Invention Registration
1761:Information disclosure statement
1042:
792:Patentable subject matter (§101)
31:
1990:United States Patents Quarterly
1597:the Supreme Court reversed the
674:provisional patent applications
433:Leahy–Smith America Invents Act
2421:(accessed on 29 November 2021)
1736:Exhausted combination doctrine
1584:teaching-suggestion-motivation
1145:International Trade Commission
1017:Pre-grant publication (PG Pub)
934:provisional patent application
854:Amgen v. Chugai Pharmaceutical
690:Fifthly, the US does not have
1:
1706:Continuing patent application
827:
778:Patent Trial and Appeal Board
516:Patent Trial and Appeal Board
74:Right granted to the inventor
3173:United States Virgin Islands
2935:Patent law in North America
1821:Prosecution history estoppel
985:Patent application procedure
685:Food and Drug Administration
236:By region / country
2134:10.1101/cshperspect.a020933
1996:United States trademark law
1811:Printed matter (patent law)
1657:, the SCOTUS's decision in
1601:’s ruling and strengthened
1590:bar was widely recognized.
1062:. The specific problem is:
3210:
2683:"Pub. L. 71-361, Sec. 337"
1661:made it easier to recover
1542:inter partes reexamination
1464:subject matter eligibility
1379:subject matter eligibility
1163:Utilization and importance
1141:US Federal District Courts
1058:to meet Knowledge (XXG)'s
1001:U.S. patent (2018-present)
943:
795:
770:US Federal District courts
293:By specific subject matter
3148:Saint Pierre and Miquelon
1962:Confederate Patent Office
1933:Patent Reform Act of 2009
1929:Patent Reform Act of 2007
1924:Patent Reform Act of 2005
1237:Fabricated Metal Products
764:comprising federal court
244:Patent Cooperation Treaty
223:Sufficiency of disclosure
202:Person skilled in the art
172:Patentable subject matter
3194:United States patent law
3168:Turks and Caicos Islands
2879:Glossary of patent terms
2068:Shurn, Peter J. (2003).
2032:35 U.S.C.A. § 154(a)(2).
1806:Petition to make special
1608:2011. Sixth Patent Act (
1595:Quanta v. LG Electronics
1147:. The decisions of the
975:Graham v. John Deere Co.
633:United States patent law
567:List of patent law cases
399:United States patent law
215:Other legal requirements
192:Industrial applicability
57:may contain suggestions.
42:may need to be rewritten
2775:56 U.S. 330, 338 (1854)
1826:Provisional application
1772:Interference proceeding
1509:federal district courts
1499:1982. Establishment of
1395:doctrine of equivalents
1151:can be appealed to the
993:U.S. patent (1985-2018)
3098:British Virgin Islands
2763:June 27, 2023, at the
1816:Prosecution disclaimer
1550:ex parte reexamination
1531:pharmaceutical patents
1490:ex parte reexamination
1375:Hotchkiss v. Greenwood
1359:
1025:, the USPTO publishes
1002:
994:
966:
917:
681:patent term adjustment
653:
454:Article of manufacture
446:Types of patent claims
3038:Saint Kitts and Nevis
2824:July 3, 2023, at the
2794:June 4, 2023, at the
2735:10.1287/mnsc.32.2.173
2520:. February 13, 2018.
2494:. December 15, 2016.
2417:June 3, 2023, at the
1897:Invention Secrecy Act
1831:Reduction to practice
1716:Doctrine of inherency
1559:the SCOTUS ended the
1440:Sherman Antitrust Act
1355:
1333:Statute of Monopolies
1000:
992:
802:One author of the US
774:declarative judgement
710:declaratory judgement
697:Sixthly, there is no
459:Composition of matter
423:Invention Secrecy Act
1567:in cases of alleged
1557:eBay v. MercExchange
1435:emerged afterwards.
1331:1623 England adopts
1259:Electrical Equipment
1069:improve this section
672:Thirdly, the US has
3053:Trinidad and Tobago
2948:Antigua and Barbuda
1856:Transitional phrase
1841:Small entity status
1836:Reissue application
1791:Micro entity status
1777:Large entity status
1767:Inter partes review
1756:Inequitable conduct
1741:First-sale doctrine
1610:America Invents Act
1569:patent infringement
1473:including previous
1387:written description
1139:hears appeals from
1109:patent infringement
747:patent infringement
645:section 8, clause 8
485:Inter partes review
123:Procedural concepts
2988:Dominican Republic
2723:Management Science
2690:www.legisworks.org
2377:"Business Methods"
2327:. April 11, 2019.
2214:on March 24, 2010.
1919:Patent Act of 1952
1914:Patent Act of 1870
1909:Patent Act of 1836
1903:Patent Act of 1790
1751:Incredible utility
1731:Duty of disclosure
1448:William O. Douglas
1157:writ of certiorari
1125:Tariff Act of 1930
1003:
995:
957:Patent Act of 1952
940:Obviousness (§103)
886:Ariosa v. Sequenom
818:for playing games
804:Patent Act of 1952
717:research exemption
699:criminal liability
557:Biological patents
228:Unity of invention
3181:
3180:
3070:other territories
2891:US code, Title 35
2884:Search US patents
2873:Consolidated laws
2600:Resources, MPEP.
2569:Resources, MPEP.
1881:
1880:
1701:Assignor estoppel
1696:All elements test
1603:patent exhaustion
1406:Winans v. Denmead
1399:Winans v. Denmead
1391:O’Reilly v. Morse
1324:
1323:
1097:
1096:
1089:
1060:quality standards
1051:This section may
870:complementary DNA
848:made clear, that
637:U.S. Constitution
607:United States law
603:
602:
393:
392:
72:
71:
46:quality standards
16:(Redirected from
3201:
3138:Saint Barthélemy
3068:Dependencies and
2941:Sovereign states
2929:
2922:
2915:
2906:
2858:
2857:
2855:
2853:
2834:
2828:
2814:
2808:
2804:
2798:
2785:
2776:
2773:
2767:
2754:
2748:
2745:
2739:
2738:
2718:
2709:
2708:
2706:
2704:
2699:on March 6, 2016
2698:
2692:. Archived from
2687:
2679:
2673:
2672:
2670:
2668:
2662:
2651:
2642:
2636:
2635:
2628:
2622:
2621:
2619:
2617:
2597:
2591:
2590:
2588:
2586:
2566:
2560:
2559:
2557:
2555:
2540:
2534:
2533:
2531:
2529:
2514:
2508:
2507:
2505:
2503:
2484:
2478:
2477:
2475:
2473:
2454:
2448:
2447:
2445:
2443:
2428:
2422:
2408:
2402:
2399:
2393:
2392:
2390:
2388:
2373:
2367:
2366:
2364:
2362:
2347:
2341:
2340:
2338:
2336:
2321:
2315:
2314:
2312:
2310:
2291:
2285:
2284:
2282:
2280:
2261:
2255:
2252:
2246:
2245:
2243:
2241:
2232:. Archived from
2222:
2216:
2215:
2210:. Archived from
2204:
2198:
2197:
2195:
2193:
2184:. Archived from
2174:
2168:
2162:
2156:
2155:
2145:
2113:
2107:
2106:
2104:
2102:
2088:
2082:
2081:
2065:
2059:
2058:
2056:
2054:
2039:
2033:
2030:
2024:
2023:
2016:
1937:Plant Patent Act
1851:Submarine patent
1690:
1640:software patents
1636:business methods
1612:) switched from
1433:dependent claims
1422:question of fact
1383:Le Roy v. Tatham
1281:Office Equipment
1179:
1153:US Supreme Court
1092:
1085:
1081:
1078:
1072:
1046:
1045:
1038:
832:
829:
824:business methods
647:, which states:
595:
588:
581:
562:Software patents
428:Hatch-Waxman Act
395:
385:
378:
371:
79:
67:
64:
58:
35:
27:
21:
3209:
3208:
3204:
3203:
3202:
3200:
3199:
3198:
3184:
3183:
3182:
3177:
3071:
3069:
3062:
2936:
2933:
2866:
2861:
2851:
2849:
2836:
2835:
2831:
2826:Wayback Machine
2815:
2811:
2805:
2801:
2796:Wayback Machine
2786:
2779:
2774:
2770:
2765:Wayback Machine
2755:
2751:
2746:
2742:
2720:
2719:
2712:
2702:
2700:
2696:
2685:
2681:
2680:
2676:
2666:
2664:
2660:
2649:
2645:James C. Yoon.
2644:
2643:
2639:
2630:
2629:
2625:
2615:
2613:
2599:
2598:
2594:
2584:
2582:
2568:
2567:
2563:
2553:
2551:
2542:
2541:
2537:
2527:
2525:
2516:
2515:
2511:
2501:
2499:
2486:
2485:
2481:
2471:
2469:
2456:
2455:
2451:
2441:
2439:
2430:
2429:
2425:
2419:Wayback Machine
2409:
2405:
2400:
2396:
2386:
2384:
2375:
2374:
2370:
2360:
2358:
2349:
2348:
2344:
2334:
2332:
2323:
2322:
2318:
2308:
2306:
2293:
2292:
2288:
2278:
2276:
2263:
2262:
2258:
2253:
2249:
2239:
2237:
2236:on June 1, 2009
2224:
2223:
2219:
2206:
2205:
2201:
2191:
2189:
2188:on June 2, 2009
2176:
2175:
2171:
2167:Knowledge (XXG)
2163:
2159:
2115:
2114:
2110:
2100:
2098:
2090:
2089:
2085:
2067:
2066:
2062:
2052:
2050:
2041:
2040:
2036:
2031:
2027:
2018:
2017:
2013:
2009:
1946:
1887:
1882:
1782:Markman hearing
1746:Flash of genius
1687:
1675:
1614:first-to-invent
1599:Federal Circuit
1588:non-obviousness
1576:non-obviousness
1561:Federal Circuit
1540:established an
1488:established an
1479:non-obviousness
1460:flash of genius
1456:non-obviousness
1414:question of law
1371:non-obviousness
1329:
1193:Pharmaceuticals
1165:
1133:
1117:
1105:
1093:
1082:
1076:
1073:
1066:
1047:
1043:
1036:
1019:
987:
977:in 1966 and in
948:
942:
909:
890:non-obviousness
830:
800:
794:
780:(PTAB). The US
743:
741:Substantive law
703:civil liability
599:
490:Markman hearing
389:
342:Patent analysis
306:Business method
75:
68:
62:
59:
49:
36:
23:
22:
15:
12:
11:
5:
3207:
3205:
3197:
3196:
3186:
3185:
3179:
3178:
3176:
3175:
3170:
3165:
3160:
3158:Sint Eustatius
3155:
3150:
3145:
3140:
3135:
3130:
3125:
3120:
3115:
3110:
3105:
3103:Cayman Islands
3100:
3095:
3090:
3085:
3080:
3074:
3072:
3067:
3064:
3063:
3061:
3060:
3055:
3050:
3045:
3040:
3035:
3030:
3025:
3020:
3015:
3010:
3005:
3000:
2995:
2990:
2985:
2980:
2975:
2970:
2965:
2960:
2955:
2950:
2944:
2942:
2938:
2937:
2934:
2932:
2931:
2924:
2917:
2909:
2903:
2902:
2893:
2888:
2887:
2886:
2881:
2876:
2865:
2864:External links
2862:
2860:
2859:
2829:
2809:
2799:
2777:
2768:
2749:
2740:
2729:(2): 173–181.
2710:
2674:
2637:
2623:
2592:
2561:
2535:
2509:
2479:
2449:
2423:
2403:
2394:
2368:
2342:
2316:
2286:
2256:
2247:
2217:
2199:
2169:
2157:
2128:(2): a020933.
2108:
2083:
2060:
2034:
2025:
2010:
2008:
2005:
2004:
2003:
1998:
1993:
1987:
1981:
1975:
1969:
1964:
1959:
1953:
1945:
1942:
1941:
1940:
1934:
1931:
1926:
1921:
1916:
1911:
1906:
1900:
1894:
1886:
1883:
1879:
1878:
1874:
1873:
1868:
1863:
1858:
1853:
1848:
1843:
1838:
1833:
1828:
1823:
1818:
1813:
1808:
1803:
1798:
1793:
1786:
1785:
1784:
1779:
1774:
1769:
1764:
1758:
1753:
1748:
1743:
1738:
1733:
1728:
1726:Duty of candor
1723:
1718:
1713:
1708:
1703:
1698:
1688:
1686:
1683:
1682:
1681:
1674:
1671:
1644:abstract ideas
1623:2012-2013. In
1580:KSR v Teleflex
1365:. Subsequent
1328:
1325:
1322:
1321:
1318:
1315:
1311:
1310:
1307:
1304:
1300:
1299:
1296:
1293:
1292:Motor Vehicles
1289:
1288:
1285:
1282:
1278:
1277:
1274:
1271:
1267:
1266:
1263:
1260:
1256:
1255:
1252:
1249:
1248:Primary Metals
1245:
1244:
1241:
1238:
1234:
1233:
1230:
1227:
1223:
1222:
1219:
1216:
1212:
1211:
1208:
1205:
1201:
1200:
1197:
1194:
1190:
1189:
1186:
1183:
1164:
1161:
1132:
1129:
1116:
1113:
1104:
1101:
1095:
1094:
1050:
1048:
1041:
1035:
1032:
1018:
1015:
986:
983:
979:KSR v Teleflex
952:inventive step
944:Main article:
941:
938:
908:
907:Novelty (§102)
905:
796:Main article:
793:
790:
742:
739:
692:utility models
601:
600:
598:
597:
590:
583:
575:
572:
571:
570:
569:
564:
559:
554:
549:
543:
541:Term of patent
538:
533:
528:
523:
518:
513:
505:
504:
500:
499:
498:
497:
492:
487:
479:
478:
474:
473:
472:
471:
466:
461:
456:
448:
447:
443:
442:
441:
440:
435:
430:
425:
420:
415:
407:
406:
402:
401:
391:
390:
388:
387:
380:
373:
365:
362:
361:
360:
359:
354:
349:
344:
336:
335:
331:
330:
329:
328:
323:
318:
313:
308:
303:
295:
294:
290:
289:
288:
287:
282:
277:
272:
267:
262:
257:
252:
247:
238:
237:
233:
232:
231:
230:
225:
217:
216:
212:
211:
210:
209:
204:
199:
194:
189:
184:
179:
174:
166:
165:
161:
160:
159:
158:
153:
148:
143:
138:
133:
125:
124:
120:
119:
118:
117:
112:
107:
102:
97:
89:
88:
84:
83:
73:
70:
69:
39:
37:
30:
24:
14:
13:
10:
9:
6:
4:
3:
2:
3206:
3195:
3192:
3191:
3189:
3174:
3171:
3169:
3166:
3164:
3161:
3159:
3156:
3154:
3151:
3149:
3146:
3144:
3141:
3139:
3136:
3134:
3131:
3129:
3126:
3124:
3121:
3119:
3116:
3114:
3111:
3109:
3106:
3104:
3101:
3099:
3096:
3094:
3091:
3089:
3086:
3084:
3081:
3079:
3076:
3075:
3073:
3065:
3059:
3058:United States
3056:
3054:
3051:
3049:
3046:
3044:
3041:
3039:
3036:
3034:
3031:
3029:
3026:
3024:
3021:
3019:
3016:
3014:
3011:
3009:
3006:
3004:
3001:
2999:
2996:
2994:
2991:
2989:
2986:
2984:
2981:
2979:
2976:
2974:
2971:
2969:
2966:
2964:
2961:
2959:
2956:
2954:
2951:
2949:
2946:
2945:
2943:
2939:
2930:
2925:
2923:
2918:
2916:
2911:
2910:
2907:
2901:
2899:
2894:
2892:
2889:
2885:
2882:
2880:
2877:
2874:
2871:
2870:
2868:
2867:
2863:
2847:
2843:
2839:
2833:
2830:
2827:
2823:
2819:
2813:
2810:
2803:
2800:
2797:
2793:
2790:
2784:
2782:
2778:
2772:
2769:
2766:
2762:
2759:
2753:
2750:
2744:
2741:
2736:
2732:
2728:
2724:
2717:
2715:
2711:
2695:
2691:
2684:
2678:
2675:
2659:
2655:
2648:
2641:
2638:
2633:
2627:
2624:
2611:
2607:
2606:www.uspto.gov
2603:
2596:
2593:
2580:
2576:
2575:www.uspto.gov
2572:
2565:
2562:
2549:
2545:
2539:
2536:
2523:
2519:
2513:
2510:
2497:
2493:
2489:
2483:
2480:
2467:
2463:
2459:
2453:
2450:
2437:
2433:
2427:
2424:
2420:
2416:
2413:
2407:
2404:
2398:
2395:
2382:
2378:
2372:
2369:
2356:
2352:
2346:
2343:
2330:
2326:
2320:
2317:
2304:
2300:
2296:
2290:
2287:
2274:
2270:
2266:
2260:
2257:
2251:
2248:
2235:
2231:
2227:
2221:
2218:
2213:
2209:
2203:
2200:
2187:
2183:
2179:
2173:
2170:
2166:
2161:
2158:
2153:
2149:
2144:
2139:
2135:
2131:
2127:
2123:
2119:
2112:
2109:
2101:September 17,
2097:
2096:Bloomberg Law
2093:
2087:
2084:
2079:
2075:
2071:
2064:
2061:
2048:
2044:
2038:
2035:
2029:
2026:
2021:
2015:
2012:
2006:
2002:
1999:
1997:
1994:
1991:
1988:
1985:
1982:
1979:
1976:
1973:
1970:
1968:
1965:
1963:
1960:
1957:
1954:
1951:
1948:
1947:
1943:
1938:
1935:
1932:
1930:
1927:
1925:
1922:
1920:
1917:
1915:
1912:
1910:
1907:
1904:
1901:
1898:
1895:
1892:
1889:
1888:
1884:
1877:
1872:
1869:
1867:
1864:
1862:
1859:
1857:
1854:
1852:
1849:
1847:
1844:
1842:
1839:
1837:
1834:
1832:
1829:
1827:
1824:
1822:
1819:
1817:
1814:
1812:
1809:
1807:
1804:
1802:
1799:
1797:
1794:
1792:
1789:
1788:
1787:
1783:
1780:
1778:
1775:
1773:
1770:
1768:
1765:
1762:
1759:
1757:
1754:
1752:
1749:
1747:
1744:
1742:
1739:
1737:
1734:
1732:
1729:
1727:
1724:
1722:
1719:
1717:
1714:
1712:
1711:Design patent
1709:
1707:
1704:
1702:
1699:
1697:
1694:
1693:
1692:
1691:
1684:
1680:
1677:
1676:
1672:
1670:
1668:
1664:
1663:attorney fees
1660:
1656:
1655:patent trolls
1651:
1649:
1645:
1641:
1637:
1632:
1630:
1626:
1621:
1619:
1618:first-to-file
1615:
1611:
1606:
1604:
1600:
1596:
1591:
1589:
1585:
1581:
1577:
1572:
1570:
1566:
1562:
1558:
1553:
1551:
1547:
1544:to allow the
1543:
1539:
1534:
1532:
1528:
1524:
1521:
1517:
1512:
1510:
1506:
1502:
1497:
1495:
1492:to allow the
1491:
1487:
1482:
1480:
1476:
1472:
1467:
1465:
1461:
1457:
1453:
1449:
1445:
1441:
1436:
1434:
1430:
1429:patent claims
1425:
1423:
1419:
1415:
1411:
1410:patent claims
1407:
1402:
1400:
1396:
1392:
1388:
1384:
1380:
1376:
1372:
1368:
1364:
1363:patent claims
1358:
1354:
1352:
1347:
1344:
1342:
1336:
1334:
1326:
1319:
1316:
1313:
1312:
1308:
1305:
1302:
1301:
1297:
1294:
1291:
1290:
1286:
1283:
1280:
1279:
1275:
1272:
1269:
1268:
1264:
1261:
1258:
1257:
1253:
1250:
1247:
1246:
1242:
1239:
1236:
1235:
1231:
1228:
1225:
1224:
1220:
1217:
1214:
1213:
1209:
1206:
1203:
1202:
1198:
1195:
1192:
1191:
1187:
1184:
1181:
1180:
1177:
1174:
1168:
1162:
1160:
1158:
1154:
1150:
1146:
1143:and from the
1142:
1138:
1130:
1128:
1126:
1122:
1114:
1112:
1110:
1102:
1100:
1091:
1088:
1080:
1077:November 2023
1070:
1065:
1061:
1057:
1056:
1049:
1040:
1039:
1033:
1031:
1028:
1024:
1016:
1014:
1012:
1008:
999:
991:
984:
982:
980:
976:
970:
965:
960:
958:
953:
947:
939:
937:
935:
929:
927:
922:
916:
912:
906:
904:
902:
897:
895:
891:
887:
883:
879:
875:
871:
867:
863:
859:
855:
851:
847:
843:
838:
836:
825:
821:
817:
811:
809:
805:
799:
791:
789:
787:
783:
779:
775:
771:
767:
763:
758:
756:
751:
750:appropriate.
748:
740:
738:
736:
735:patent trolls
731:
729:
724:
722:
718:
713:
711:
706:
704:
700:
695:
693:
688:
686:
682:
677:
675:
670:
668:
663:
661:
656:
652:
648:
646:
642:
638:
634:
630:
628:
624:
620:
616:
612:
608:
596:
591:
589:
584:
582:
577:
576:
574:
573:
568:
565:
563:
560:
558:
555:
553:
550:
547:
544:
542:
539:
537:
534:
532:
529:
527:
524:
522:
519:
517:
514:
512:
509:
508:
507:
506:
501:
496:
495:Reexamination
493:
491:
488:
486:
483:
482:
481:
480:
475:
470:
467:
465:
462:
460:
457:
455:
452:
451:
450:
449:
444:
439:
436:
434:
431:
429:
426:
424:
421:
419:
418:Bayh–Dole Act
416:
414:
411:
410:
409:
408:
403:
400:
396:
386:
381:
379:
374:
372:
367:
366:
364:
363:
358:
355:
353:
350:
348:
345:
343:
340:
339:
338:
337:
332:
327:
324:
322:
319:
317:
314:
312:
309:
307:
304:
302:
299:
298:
297:
296:
291:
286:
285:United States
283:
281:
278:
276:
273:
271:
268:
266:
263:
261:
258:
256:
253:
251:
248:
245:
242:
241:
240:
239:
234:
229:
226:
224:
221:
220:
219:
218:
213:
208:
205:
203:
200:
198:
195:
193:
190:
188:
185:
183:
180:
178:
175:
173:
170:
169:
168:
167:
162:
157:
154:
152:
149:
147:
144:
142:
139:
137:
134:
132:
129:
128:
127:
126:
121:
116:
113:
111:
108:
106:
103:
101:
98:
96:
93:
92:
91:
90:
85:
80:
77:
66:
56:
52:
47:
43:
40:This article
38:
34:
29:
28:
19:
3163:Sint Maarten
3143:Saint Martin
2897:
2850:. Retrieved
2842:pubs.acs.org
2841:
2832:
2812:
2802:
2771:
2752:
2743:
2726:
2722:
2701:. Retrieved
2694:the original
2689:
2677:
2665:. Retrieved
2654:stanford.edu
2653:
2640:
2626:
2614:. Retrieved
2605:
2595:
2583:. Retrieved
2574:
2564:
2552:. Retrieved
2538:
2526:. Retrieved
2512:
2500:. Retrieved
2491:
2482:
2470:. Retrieved
2461:
2452:
2440:. Retrieved
2426:
2406:
2397:
2385:. Retrieved
2371:
2359:. Retrieved
2345:
2333:. Retrieved
2319:
2307:. Retrieved
2298:
2289:
2277:. Retrieved
2268:
2259:
2250:
2238:. Retrieved
2234:the original
2229:
2226:"35 USC 103"
2220:
2212:the original
2208:"35 USC 102"
2202:
2190:. Retrieved
2186:the original
2181:
2178:"35 USC 101"
2172:
2160:
2125:
2121:
2111:
2099:. Retrieved
2095:
2086:
2077:
2073:
2063:
2051:. Retrieved
2037:
2028:
2014:
1875:
1652:
1633:
1622:
1607:
1592:
1573:
1554:
1535:
1513:
1498:
1483:
1468:
1437:
1426:
1418:infringement
1403:
1360:
1356:
1348:
1345:
1337:
1330:
1172:
1169:
1166:
1134:
1118:
1106:
1098:
1083:
1074:
1067:Please help
1063:
1052:
1020:
1004:
971:
967:
962:
949:
930:
925:
921:every aspect
920:
918:
914:
910:
898:
877:
849:
839:
819:
812:
801:
759:
752:
744:
732:
725:
714:
707:
696:
689:
678:
671:
664:
657:
654:
650:
632:
631:
604:
526:Infringement
503:Other topics
398:
347:Pirate Party
284:
177:Inventorship
156:Infringement
100:Patent claim
76:
60:
51:You can help
41:
3133:Puerto Rico
3043:Saint Lucia
2993:El Salvador
1891:28 USC 1498
1885:Legislation
1801:On-sale bar
1565:injunctions
1538:US Congress
1525:encouraged
1486:US Congress
1270:Instruments
1071:if you can.
864:decided in
831: 1990
641:Article One
623:non-obvious
405:Legislation
280:Netherlands
136:Prosecution
131:Application
18:U.S. patent
3128:Montserrat
3123:Martinique
3118:Guadeloupe
2973:Costa Rica
2875:(pdf, 1MB)
2852:January 5,
2299:LexisNexis
2007:References
1667:plaintiffs
1642:and other
1605:doctrine.
1450:developed
1393:) and the
1351:enablement
1021:Since the
766:precedents
715:Eighthly,
521:Exhaustion
477:Procedures
301:Biological
141:Opposition
82:Patent law
3113:Greenland
3028:Nicaragua
3003:Guatemala
2807:Hamersky.
2616:March 11,
2462:uspto.gov
2269:uspto.gov
2230:uspto.gov
2182:uspto.gov
1593:2008. In
1555:2006. In
1471:U.S. Code
1404:1854. In
1341:IP clause
1226:Machinery
1215:Petroleum
1204:Chemicals
981:in 2006.
316:Insurance
250:Australia
207:Prior art
151:Licensing
146:Valuation
115:Criticism
110:Economics
87:Overviews
63:June 2023
55:talk page
3188:Category
3078:Anguilla
3013:Honduras
2983:Dominica
2958:Barbados
2846:Archived
2822:Archived
2792:Archived
2761:Archived
2667:June 10,
2658:Archived
2610:Archived
2585:June 13,
2579:Archived
2548:Archived
2522:Archived
2502:June 10,
2496:Archived
2472:June 10,
2466:Archived
2436:Archived
2415:Archived
2381:Archived
2355:Archived
2329:Archived
2303:Archived
2279:June 10,
2273:Archived
2152:25359549
2047:Archived
1871:X-Patent
1685:Concepts
1673:See also
1475:case law
1452:case law
1367:case law
1314:Textiles
1182:Industry
1053:require
1013:(MPEP).
872:without
837:(2014).
762:case law
728:case law
721:fair use
357:Glossary
352:Category
334:See also
321:Software
311:Chemical
3108:Curaçao
3093:Bonaire
3088:Bermuda
3018:Jamaica
2998:Grenada
2953:Bahamas
2703:May 10,
2554:May 30,
2528:July 3,
2442:May 30,
2387:May 10,
2361:July 3,
2335:July 3,
2309:July 3,
2240:June 1,
2192:June 2,
2143:4315915
2053:May 31,
1986:(USPTO)
1952:(AIPLA)
1866:Utility
1527:generic
1327:History
1055:cleanup
878:routine
874:introns
850:trivial
552:History
464:Machine
270:Germany
197:Utility
182:Novelty
105:History
3033:Panama
3023:Mexico
2968:Canada
2963:Belize
2900:(2021)
2602:"MPEP"
2571:"MPEP"
2150:
2140:
1992:(USPQ)
1980:(CCPA)
1974:(CAFC)
1958:(BPAI)
1939:(1930)
1899:(1951)
1876:
1629:Myriad
1536:1999.
1520:Waxman
1514:1984.
1484:1980.
1462:) and
1446:under
1444:SCOTUS
1438:1890.
1303:Rubber
1027:patent
862:SCOTUS
846:SCOTUS
786:SCOTUS
621:, and
619:useful
611:patent
548:(MPEP)
536:Racism
531:Misuse
469:Method
265:Europe
255:Canada
95:Patent
53:. The
3083:Aruba
3008:Haiti
2697:(PDF)
2686:(PDF)
2661:(PDF)
2650:(PDF)
2492:USPTO
1944:Other
1763:(IDS)
1665:from
1546:USPTO
1516:Hatch
1505:USPTO
1494:USPTO
1458:(see
1420:is a
1412:is a
808:USPTO
639:, in
275:Japan
260:China
246:(PCT)
3153:Saba
2978:Cuba
2854:2007
2705:2017
2669:2023
2618:2013
2587:2008
2556:2020
2530:2023
2504:2023
2474:2023
2444:2023
2389:2023
2363:2023
2337:2023
2311:2023
2281:2023
2242:2009
2194:2009
2148:PMID
2103:2023
2080:(1).
2055:2023
1646:in
1627:and
1625:Mayo
1507:and
1149:CAFC
1135:The
858:CAFC
856:the
844:the
816:dice
719:and
669:).
662:),
609:, a
2820:"1
2731:doi
2138:PMC
2130:doi
1616:to
1477:on
1454:on
1401:).
1385:),
1377:),
1265:11
1243:12
1232:17
1221:25
1210:38
1199:60
1173:not
820:may
627:FDA
615:new
326:Tax
3190::
2844:.
2840:.
2780:^
2727:32
2725:.
2713:^
2688:.
2656:.
2652:.
2608:.
2604:.
2577:.
2573:.
2546:.
2490:.
2464:.
2460:.
2434:.
2379:.
2353:.
2301:.
2297:.
2271:.
2267:.
2228:.
2180:.
2146:.
2136:.
2124:.
2120:.
2094:.
2076:.
2072:.
2045:.
1638:,
1620:.
1533:.
1511:.
1481:.
1320:0
1309:0
1298:0
1287:0
1276:1
1254:1
1240:12
1229:15
1218:18
1207:30
1196:65
1159:.
828:c.
705:.
694:.
687:.
643:,
617:,
2928:e
2921:t
2914:v
2856:.
2737:.
2733::
2707:.
2671:.
2634:.
2620:.
2589:.
2558:.
2532:.
2506:.
2476:.
2446:.
2391:.
2365:.
2339:.
2313:.
2283:.
2244:.
2196:.
2154:.
2132::
2126:5
2105:.
2078:3
2057:.
2022:.
1518:-
1397:(
1389:(
1381:(
1373:(
1317:0
1306:0
1295:0
1284:0
1273:1
1262:4
1251:8
1090:)
1084:(
1079:)
1075:(
594:e
587:t
580:v
384:e
377:t
370:v
65:)
61:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
